@FierceMedDev: Exact Sciences signs on Anthem and Aetna to noninvasive colon cancer Dx. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: ICYMI yesterday: FDA approves novel blood purifier that treats rare condition in hemodialysis patients. Report | Follow @VarunSaxena2
@EmilyWFierce: Check out FierceBiotech Radio's latest podcast with Express Scripts CMO Steve Miller on iTunes. | Follow @EmilyWFierce
> Diagnostics player AltheaDx has withdrawn its IPO, just as disposable insulin pump maker Valeritas and wearable pump maker SteadyMed set terms for their IPOs to raise $75 million and $55 million, respectively. More
> Sorin has joined eight other European companies, research institutes and universities as part of the EU-funded, Smart-MEMPHIS project that is focused on energy harvesting systems that could be used to power minimally invasive pacemakers. More
> U.K. intellectual property commercialization company IP Group has raised a fund £128 million ($193.2 million) fund. Its portfolio of about 90 healthcare, biotech, cleantech and information technology companies includes DNA sequencing player Oxford Nanopore Technologies. Statement (PDF)
> InspireMD has raised about $13.7 million in a financing intended to back a launch for its CGuard Embolic Prevention System. Release
Biotech News
@FierceBiotech: FierceBiotech Radio with Express Scripts' Steve Miller. More | Follow @FierceBiotech
@JohnCFierce: Biopharma's new normal: Constant makeovers leave R&D jobs at permanent risk. Editor's corner | Follow @JohnCFierce
@DamianFierce: Hey @FierceBiotech's podcast is now available on Stitcher. If you know what that means, here you go. | Follow @DamianFierce
> Collegium bags $50M to get its abuse-deterrent painkiller through the FDA. News
> FDA panel backs Kythera's double chin-fighting shot. Story
> Eyeing an FDA filing, Ocular Therapeutix drug hits PhIIIa goals. Article
Pharma News
@FiercePharma: Bayer puts cancer-fighting country crooner onstage to promote colonoscopies. FiercePharmaMarketing article | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: MS Pharma in Jordan gets $30M development loan to expand its drug manufacturing. Story | Follow @EricPFierce
@CarlyHFierce: ICYMI: GSK sacks 100-plus China workers for misconduct in wake of bribery scandal. Report | Follow @CarlyHFierce
> Activist investor Ackman nabs $3B-plus stake in former takeover partner Valeant. Report
> New Bristol-Myers CEO on tap for $8.7M-plus pay package. Story
> Concordia scores ex-Big Pharma drugs in $1.2B Covis buyout.Article
Biotech Research News
> Mouse model for rheumatoid arthritis responds to M-MDSCs. Item
> Salk scientists use new CRISPR tech to chop up HIV. More
> Activating thyroid hormone receptor may rev up metabolism. Story
> UC Berkeley team puts its heart into latest organ-on-a-chip project. Article
> Mayo/Scripps team begins testing a new class of anti-aging drugs. Report
Pharma Manufacturing News
> Sun's buyout of Ranbaxy gets India's approval. Item
> U.S. biotech buying Belgium cell manufacturer for $25M. News
> Hospira recalls more saline as well as drug used during pregnancy. Report
> Patheon strikes again; deal for Agere its second in a week. Story
> Recro picks up Alkermes plant, pain drugs and contract biz. Article
Pharma Asia News
> Boehringer Spiriva patent revoked in Cipla challenge in India. Item
> SK Chemicals gets Korea nod for cell-culture flu vaccine 'SKYCellflu.' Report
> Japan's R-Tech Ueno evaluates options as PhIII candidate Unoprostone fails primary endpoint. More
> Sun and Ranbaxy now a couple as last hurdle cleared for India's top drug company. Story
> Sri Lanka poised to launch mandatory generics-first policy. Article